Alan Crane
14Patents
3h-index
18Co-inventors
49Inventor score
Filing activity: Sep 11, 2014 → Oct 19, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10961310B2 | Targeted immunotolerance | Chemistry; Metallurgy | 4 | Active |
| US9833513B2 | Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US9913905B2 | Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US9925263B2 | Liquid pharmaceutical formulations for injection comprising procaine and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10179172B2 | Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11471479B2 | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents | Human Necessities | 1 | Active |
| US10849977B2 | Liquid Protein Formulations Containing Thiamine | Emerging Cross-Sectional Technologies | 1 | Active |
| US10821184B2 | Liquid protein formulations containing thiamine pyrophosphate (TPP) | Emerging Cross-Sectional Technologies | 1 | Active |
| US11986526B2 | Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC) | Emerging Cross-Sectional Technologies | 0 | Active |
| US11819550B2 | Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP) | Emerging Cross-Sectional Technologies | 0 | Active |
| US11433136B2 | Polyacetal polymers, conjugates, particles and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10646571B2 | Liquid protein formulations containing cimetidine | Emerging Cross-Sectional Technologies | 0 | Active |
| US10053391B2 | Glaze-like coatings used to make oven bake clays food and drink safe | Chemistry; Metallurgy | 0 | Active |
| US10821183B2 | Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM) | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.